In December, CHS completed a cash tender offer of $1 billion in senior notes due in 2015, which was funded by proceeds from the sale of $1 billion in senior notes due in 2019.
Net operating revenue in the fourth quarter increased 3.9 percent from the same period last year to $3.4 billion. Adjusted EBITDA in the fourth quarter was $463.8 million, an increase of 2.8 percent compared with $451.1 million in the fourth quarter of 2010.
For the entire 2011 fiscal year, CHS recorded net income of $201.9 million, a decrease of 27.9 percent. Net operating revenue on the year jumped 7.9 percent, from $12.6 billion in 2010 to $13.6 billion last year. Adjusted EBITDA was $1.8 billion for both years.
CHS also released same-hospital metrics for the fourth quarter and entire 2011 fiscal year. Admissions and adjusted admissions fell 6.7 percent and 1.4 percent, respectively, in the fourth quarter. On the year, admissions and adjusted admissions dropped 5.6 percent and 0.7 percent, respectively.
CHS’ same-hospital occupancy rate fell from 50.2 percent in FY 2010 to 48.9 percent in FY 2011. The average length of stay increased from 4.3 days in FY 2010 to 4.4 days in FY 2011.
Related Articles on CHS:
Community Health Systems Forms Commonwealth Health
CHS Extends $1.6B of Term Loans to 2017
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
